THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
Guangxi Province
People’s Republic of China (PRC)
management
prevention and control
thalassemia
Journal
Hemoglobin
ISSN: 1532-432X
Titre abrégé: Hemoglobin
Pays: England
ID NLM: 7705865
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
13
8
2022
Statut:
ppublish
Résumé
Guangxi Province is located in the southwest of the People's Republic of China (PRC). The province has a population of 50.12 million with a birth rate of 13.31%. Thalassemia is a major health problem in Guangxi Province. About 20.0-25.0% of the population carries thalassemia genes, which is acknowledged to be the highest prevalence in China. National and provincial programs for thalassemia prevention and control have been introduced. Premarital screening and prenatal diagnosis (PND) for the prevention of thalassemic fetuses are available. Blood transfusions, iron chelation therapy, and stem cell transplantation are also available for transfusion-dependent thalassemic patients.
Identifiants
pubmed: 35950576
doi: 10.1080/03630269.2021.2008960
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM